Early Intervention With Non-ablative Fractional Laser to Reduce Cutaneous Scarring

To investigate intervention with early application of non-ablative laser to prevent scarring in the skin

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cicatrix Fibrosis Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Bispebjerg Hospital

Copenhagen, Denmark

About this study

To intervene in scar formation at three different time-points

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

good health
men
Skin type 2-3
non-smokers
presenting full medical record

Exclusion criteria

active skin disease in test area
resent UV-exposure in test area
history of keloid
current or resent cancer
uncontrolled systemical disease

Treatment and study plan

non-ablative laser

Device

non-abaltive laser pre, immediate and post wounding

Other names: Erbium:glass laser, 1540 nm laser

Primary outcomes

To measure the clinical effect on scarring of non-ablative laser intervention at the three time-points

Time frame: 3 months after

Clinical evaluation by scar scales

Sponsors and collaborators

Lead sponsor

Bispebjerg Hospital

Other

Registry information

Important dates

Study start: 2015
Primary completion: 2015
Study completion: 2016
First posted: Jan 5, 2016
Registry last updated: Feb 9, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed